glp 1 for nash Possible hepatoprotective effects of GLP-1 receptor agonists The Role of GLP1-RAs in

Promising data has fueled some scientific speculation and hypothesis generation that suggests there may be therapeutic and even curative potential for GLP-1s

Patients should read that consent line carefully rather than checking it on autopilot

If approved for the treatment of obesity, orforglipron could provide a convenient alternative for the millions of individuals living with obesity around the globe to continue their long-term health journey, said Kenneth Custer, executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company

LUPKIN: And I also love that

Predictors of response to dipeptidyl peptidase-4 inhibitors: Evidence from randomized clinical trials